GATA2 and myelodysplastic syndrome: In particular, GATA2 analysis has to be included in the workup of all young adults and children above the age of four diagnosed with MDS associated with monosomy 7, trisomy 8, or der(1;7), regardless of the presence of a clinical phenotype suggestive to GATA2-deficency or the family history.